Miracle Mile Advisors LLC Buys 1,095 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Miracle Mile Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 26,100 shares of the healthcare conglomerate’s stock after purchasing an additional 1,095 shares during the period. Miracle Mile Advisors LLC’s holdings in UnitedHealth Group were worth $12,912,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Hodges Capital Management Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $1,127,000. SRS Capital Advisors Inc. increased its position in UnitedHealth Group by 18.1% in the 3rd quarter. SRS Capital Advisors Inc. now owns 1,977 shares of the healthcare conglomerate’s stock valued at $997,000 after buying an additional 303 shares in the last quarter. Axxcess Wealth Management LLC lifted its stake in UnitedHealth Group by 30.6% in the third quarter. Axxcess Wealth Management LLC now owns 26,760 shares of the healthcare conglomerate’s stock valued at $13,492,000 after purchasing an additional 6,274 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in UnitedHealth Group by 20.1% in the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after purchasing an additional 623,631 shares during the last quarter. Finally, Alps Advisors Inc. lifted its stake in UnitedHealth Group by 111.0% in the third quarter. Alps Advisors Inc. now owns 40,915 shares of the healthcare conglomerate’s stock valued at $20,629,000 after purchasing an additional 21,526 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 2.9 %

UNH opened at $494.43 on Tuesday. The company has a market cap of $455.07 billion, a P/E ratio of 30.22, a P/E/G ratio of 1.48 and a beta of 0.60. The business’s 50-day moving average price is $498.34 and its 200-day moving average price is $501.63. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Barclays upped their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Morgan Stanley cut their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, June 12th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday. Finally, Wells Fargo & Company lowered their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.